Health Sciences Acquisitions Corporation 2 is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The sponsor of the Company is HSAC 2 Holdings, LLC, an affiliate of RTW Investments, LP. HSAC 2 anticipates targeting companies domiciled in North America or Europe that are developing assets in the biopharmaceutical and medical technology sectors, which aligns with the Company's management team's experience in healthcare investing and drug development.
Company profile
Ticker
OBIO, HSAQ
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
SEC CIK
Corporate docs
Subsidiaries
HSAC Olympus Merger Sub, Inc. ...
OBIO stock data
Latest filings (excl ownership)
10-K
2022 FY
Annual report
25 Jan 23
425
Business combination disclosure
25 Jan 23
8-K
Departure of Directors or Certain Officers
25 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Jan 23
8-K
Other Events
23 Jan 23
425
Business combination disclosure
10 Jan 23
8-K
Material Modifications to Rights of Security Holders
21 Dec 22
EFFECT
Notice of effectiveness
19 Dec 22
424B3
Prospectus supplement
16 Dec 22
SEC STAFF LETTER
SEC staff letter
16 Dec 22
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 175.16 k | 175.16 k | 175.16 k | 175.16 k | 175.16 k | |
| Cash burn (monthly) | 186.69 k | 131.61 k | 292.24 k | 256.69 k | 89.21 k | |
| Cash used (since last report) | 190.69 k | 134.43 k | 298.51 k | 262.20 k | 91.12 k | |
| Cash remaining | -15.53 k | 40.73 k | -123.35 k | -87.04 k | 84.04 k | |
| Runway (months of cash) | -0.1 | 0.3 | -0.4 | -0.3 | 0.9 | |
Institutional ownership, Q3 2022
89.7% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 24 |
| Opened positions | 4 |
| Closed positions | 42 |
| Increased positions | 2 |
| Reduced positions | 9 |
| 13F shares | Current |
|---|---|
| Total value | 112.26 mm |
| Total shares | 10.06 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| HSAC 2 | 4.36 mm | $55.86 mm |
| RTW Investments | 1.00 mm | $9.90 mm |
| BLK Blackrock | 790.44 k | $7.83 mm |
| T. Rowe Price | 724.57 k | $7.18 mm |
| Ra Capital Management | 610.28 k | $6.04 mm |
| Boxer Capital | 400.00 k | $3.96 mm |
| EcoR1 Capital | 400.00 k | $3.96 mm |
| Avidity Partners Management | 400.00 k | $3.96 mm |
| Tang Capital Management | 392.50 k | $3.89 mm |
| Sio Capital Management | 250.00 k | $2.48 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 Jan 23 | Geoffrey Wade Smith | Common Stock | Grant | Acquire A | Yes | No | 0 | 256,623 | 0.00 | 256,623 |
| 26 Jan 23 | Geoffrey Wade Smith | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,049,224 | 0.00 | 1,049,224 |
| 26 Jan 23 | Geoffrey Wade Smith | Common Stock | Grant | Acquire A | Yes | No | 0 | 201,319 | 0.00 | 201,319 |
| 26 Jan 23 | Geoffrey Wade Smith | Common Stock | Grant | Acquire A | No | No | 0 | 3,488 | 0.00 | 3,488 |
| 26 Jan 23 | Geoffrey Wade Smith | Stock Options Common Stock | Grant | Acquire A | No | No | 10 | 23,250 | 232.50 k | 23,250 |
| 26 Jan 23 | Geoffrey Wade Smith | Stock Options Common Stock | Grant | Acquire A | No | No | 4.3011 | 6,975 | 30.00 k | 6,975 |
| 26 Jan 23 | Geoffrey Wade Smith | Stock Options Common Stock | Grant | Acquire A | No | No | 4.3011 | 18,600 | 80.00 k | 18,600 |
| 26 Jan 23 | Geoffrey Wade Smith | Warrants Common Stock | Grant | Acquire A | Yes | No | 21.5054 | 519 | 11.16 k | 519 |
| 26 Jan 23 | Geoffrey Wade Smith | Warrants Common Stock | Grant | Acquire A | Yes | No | 21.5054 | 136,097 | 2.93 mm | 136,097 |
| 26 Jan 23 | Geoffrey Wade Smith | Warrants Common Stock | Grant | Acquire A | Yes | No | 21.5054 | 43,940 | 944.95 k | 43,940 |